Hemoglobin and Hematocrit Levels in the Prediction of Complicated Crohn%26apos;s Disease Behavior - A Cohort Study

作者：Rieder Florian^*; Paul Gisela; Schnoy Elisabeth; Schleder Stephan; Wolf Alexandra; Kamm Florian; Dirmeier Andrea; Strauch Ulrike; Obermeier Florian; Lopez Rocio; Achkar Jean Paul; Rogler Gerhard; Klebl Frank

来源：PLos One, 2014, 9(8): e104706.

DOI：10.1371/journal.pone.0104706

Background: Markers that predict the occurrence of a complicated disease behavior in patients with Crohn%26apos;s disease (CD) can permit a more aggressive therapeutic regimen for patients at risk. The aim of this cohort study was to test the blood levels of hemoglobin (Hgb) and hematocrit (Hct) for the prediction of complicated CD behavior and CD related surgery in an adult patient population. %26lt;br%26gt;Methods: Blood samples of 62 CD patients of the German Inflammatory Bowel Disease-network %26quot;Kompetenznetz CED%26apos;%26apos; were tested for the levels of Hgb and Hct prior to the occurrence of complicated disease behavior or CD related surgery. The relation of these markers and clinical events was studied using Kaplan-Meier survival analysis and adjusted COX-proportional hazard regression models. %26lt;br%26gt;Results: The median follow-up time was 55.8 months. Of the 62 CD patients without any previous complication or surgery 34% developed a complication and/or underwent CD related surgery. Low Hgb or Hct levels were independent predictors of a shorter time to occurrence of the first complication or CD related surgery. This was true for early as well as late occurring complications. Stable low Hgb or Hct during serial follow-up measurements had a higher frequency of complications compared to patients with a stable normal Hgb or Hct, respectively. %26lt;br%26gt;Conclusions: Determination of Hgb or Hct in complication and surgery naive CD patients might serve as an additional tool for the prediction of complicated disease behavior.

• 出版日期2014-8-12